tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

BDRX Stock Latest News

Biodexa Pharmaceuticals Lowers Warrant Exercise Price to Boost Capital
Company AnnouncementsBiodexa Pharmaceuticals Lowers Warrant Exercise Price to Boost Capital
6d ago
6K
BDRX
Biodexa Pharmaceuticals Secures EU Orphan Drug Designation for eRapa in FAP
PremiumCompany Announcements
Biodexa Pharmaceuticals Secures EU Orphan Drug Designation for eRapa in FAP
9d ago
6K
BDRX
Biodexa Pharmaceuticals receives orphan drug designation in Europe for eRapa
PremiumThe Fly
Biodexa Pharmaceuticals receives orphan drug designation in Europe for eRapa
9d ago
BDRX
Biodexa Pharmaceuticals Faces Setback as Key Resolution Fails at General Meeting
PremiumCompany Announcements
Biodexa Pharmaceuticals Faces Setback as Key Resolution Fails at General Meeting
19d ago
6K
BDRX
Biodexa Pharmaceuticals Announces General Meeting for Strategic Share Resolutions
PremiumCompany Announcements
Biodexa Pharmaceuticals Announces General Meeting for Strategic Share Resolutions
1M ago
6K
BDRX
Biodexa Pharmaceuticals Reports 2024 Preliminary Results and 2025 Strategic Priorities
PremiumCompany AnnouncementsBiodexa Pharmaceuticals Reports 2024 Preliminary Results and 2025 Strategic Priorities
1M ago
6K
BDRX
Biodexa reports preliminary FY24 EPS GBP (0.1)p vs GBP (2)p last year
Premium
The Fly
Biodexa reports preliminary FY24 EPS GBP (0.1)p vs GBP (2)p last year
1M ago
BDRX
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
IBO
LLY
3 Penny Stocks to Watch Now, 3/20/25
PremiumMarket News
3 Penny Stocks to Watch Now, 3/20/25
2M ago
ATER
BDRX
Biodexa says on track to initiate Phase 3 trial in FAP next quarter
PremiumThe Fly
Biodexa says on track to initiate Phase 3 trial in FAP next quarter
2M ago
BDRX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
AEON
APRE
Biodexa Pharmaceuticals Advances Phase 3 eRapa Program with FDA Approval
PremiumCompany Announcements
Biodexa Pharmaceuticals Advances Phase 3 eRapa Program with FDA Approval
2M ago
6K
BDRX
Biodexa Pharmaceuticals announces outcome of a Type C meeting with FDA on eRapa
PremiumThe FlyBiodexa Pharmaceuticals announces outcome of a Type C meeting with FDA on eRapa
2M ago
BDRX
Biodexa Pharmaceuticals announces appointment of Precision for Medicine as CRO
Premium
The Fly
Biodexa Pharmaceuticals announces appointment of Precision for Medicine as CRO
3M ago
BDRX
Biodexa Pharmaceuticals Secures U.S. Patent for eRapa, Plans Phase 3 Study
Premium
Company Announcements
Biodexa Pharmaceuticals Secures U.S. Patent for eRapa, Plans Phase 3 Study
3M ago
6K
BDRX
Biodexa Pharmaceuticals announces allowance of U.S. patent covering eRapa
PremiumThe Fly
Biodexa Pharmaceuticals announces allowance of U.S. patent covering eRapa
3M ago
BDRX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
BDRX
FHTX
Biodexa Pharmaceuticals to Present at Emerging Growth Conference
PremiumCompany Announcements
Biodexa Pharmaceuticals to Present at Emerging Growth Conference
3M ago
6K
BDRX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
AXSM
BDRX
Biodexa Pharmaceuticals receives Fast Track designation for eRapa
PremiumThe FlyBiodexa Pharmaceuticals receives Fast Track designation for eRapa
3M ago
BDRX
Biodexa Pharmaceuticals Receives FDA Fast Track for eRapa in FAP Treatment
Premium
Company Announcements
Biodexa Pharmaceuticals Receives FDA Fast Track for eRapa in FAP Treatment
3M ago
6K
BDRX
Biodexa Pharmaceuticals Enhances Leadership with New Chief Medical Officer
Premium
Company Announcements
Biodexa Pharmaceuticals Enhances Leadership with New Chief Medical Officer
4M ago
6K
BDRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >